Muhammad Munir, MD
Cardiovascular Disease · Sacramento, CANPI 1447505607
Payments from drug & device makers
What this record shows
This record is dominated by grants: $40,446 of the $62,959 with a category attached, or 64.2%. 9 manufacturers reported payments, led by Medtronic at 39.7% of the total. Reporting peaked in 2021 at $30,984 and has fallen 93.6% since, to $1,978 in 2025. Among cardiovascular disease clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 171 payments — averaging $368.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$25K
- Abbott$16K
- Biotronik Inc.$13K
- Boston Scientific$8K
- Biosense Webster, Inc.$573
- Cardiva Medical, Inc.$53
- plus $96 from 3 others
What the payments were for
- Grants$40,44664%
- Travel & lodging$14,86824%
- Food & beverage$6,84511%
- Education$8001%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 31 | $24,969 |
| Abbott | 26 | $15,910 |
| Biotronik Inc. | 81 | $13,247 |
| Boston Scientific | 12 | $8,111 |
| Biosense Webster, Inc. | 14 | $573 |
| Cardiva Medical, Inc. | 2 | $53 |
| Irhythm Technologies, Inc. | 2 | $48 |
| Philips North America LLC | 2 | $29 |
| Convatec Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL BRADY$7,500
- AVEIR$3,757
- Acticor 7 VR-T DX$2,738
- Arctic Front$1,042
- Selectra$842
- Sentus$766
- Rivacor 7 DR-T$766
- Edora 8 DR-T$766
- Micra$351
- AMVIA EDGE$233
- GENERAL - THERAPIES$226
- Ensite Cardiac Mapping System$186
- LINQ II$157
- ENSITE PRECISION$146
- BioMonitor$118
- Carto 3$103
How this compares
$62,959 in reported general payments places this provider in the 95th percentile of 2,184 cardiovascular disease providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 95 | $145,294 |
| XareltoRivaroxaban | 45 | $56,455 |
| MultaqDronedarone Hcl | 24 | $36,258 |
| Amiodarone Hcl | 93 | $2,574 |
| Metoprolol Succinate | 76 | $1,022 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 12 | $234 |
| Metoprolol Tartrate | 13 | $146 |
| Atorvastatin Calcium | 17 | $100 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Sacramento
- Jason RogersSacramento$4.4M
- Gagan SinghSacramento$1.2M
- Thomas SmithSacramento$942K
- Edris AmanSacramento$516K
- Garrett WongSacramento$504K
- William BommerSacramento$194K
- Jeffrey SouthardSacramento$193K
- Andrea SoaresSacramento$159K
- Ted LoveHillsborough$102.8M
- Paul KurthSanta Barbara$6.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.